Get Your Personalized Supplement StackSupplement Stack Quiz

Epimedium leaf extract

Also known as: Epimedium koreanum, Epimedium brevicornum, Horny Goat Weed, Yin Yang Huo, Epimedium sagittatum

Overview

Epimedium Leaf Extract is derived from the aerial parts of *Epimedium* plants, primarily *Epimedium sagittatum*, *Epimedium koreanum*, and *Epimedium brevicornum*, native to East Asia. It is commonly known as Horny Goat Weed or Yin Yang Huo in Traditional Chinese Medicine. The extract is rich in flavonoids, with icariin identified as the main bioactive compound responsible for its therapeutic effects. Traditionally, Epimedium has been used for its purported benefits in bone health, particularly in managing osteoporosis, and for addressing sexual dysfunction, such as erectile dysfunction. It also exhibits anti-inflammatory properties. Research into Epimedium's efficacy is ongoing, with several randomized controlled trials and meta-analyses supporting its traditional uses, though some studies have limitations regarding sample size and standardization of extracts. It is classified as a flavonoid-rich botanical extract.

Benefits

Epimedium Leaf Extract offers several evidence-based benefits, primarily due to its flavonoid content, especially icariin: * **Osteoporosis Treatment:** Meta-analyses consistently show that Epimedium total flavonoids (EF) can significantly improve bone mineral density (BMD) and reduce markers of bone turnover in patients with primary osteoporosis. These effects are statistically significant compared to control groups, indicating a clinically relevant impact on bone health. The evidence for this benefit is moderate to strong, supported by multiple systematic reviews. * **Erectile Dysfunction (ED):** Some randomized controlled trials suggest that Epimedium-containing formulations can improve erectile function scores (IIEF). While often studied in combination with other herbs, the improvements observed were statistically significant, though modest. The evidence for ED is moderate, with a need for more single-ingredient trials to confirm efficacy. * **Anti-inflammatory Effects:** In vitro and animal studies demonstrate that Epimedium exhibits anti-inflammatory properties. It achieves this by inhibiting key inflammatory pathways, such as NF-κB and MAPK, and by reducing the production of pro-inflammatory cytokines like IL-6 and TNF-α. While promising, most of this evidence is preclinical. Epimedium appears most beneficial for middle-aged and older adults experiencing osteoporosis or mild-to-moderate erectile dysfunction. For bone health, benefits are typically observed over weeks to months, while improvements in erectile function may be seen within a shorter timeframe.

How it works

Epimedium Leaf Extract exerts its therapeutic effects through several biological pathways, primarily mediated by its active compound, icariin. For bone health, icariin and other flavonoids stimulate osteoblast activity, promoting new bone formation, and simultaneously inhibit osteoclastogenesis, which reduces bone resorption. This dual action helps to improve bone mineral density and overall bone metabolism. In the context of erectile dysfunction, icariin functions as a phosphodiesterase type 5 (PDE5) inhibitor. By inhibiting PDE5, icariin increases the levels of cyclic guanosine monophosphate (cGMP) in penile smooth muscle, leading to enhanced nitric oxide (NO)-mediated vasodilation and improved blood flow, which is crucial for achieving and maintaining an erection. Furthermore, Epimedium's anti-inflammatory effects stem from its ability to suppress key inflammatory signaling pathways, such as NF-κB and MAPK, thereby reducing the production of pro-inflammatory mediators. Icariin is absorbed orally but undergoes metabolism, with moderate bioavailability that may be enhanced by specific formulations.

Side effects

Epimedium Leaf Extract is generally well tolerated, with clinical trials reporting no serious adverse events. The most commonly reported side effect is mild gastrointestinal discomfort, which occurs infrequently. Uncommon or rare severe side effects have not been significantly reported in high-quality clinical trials. However, caution is advised regarding potential drug interactions. Due to its vasodilatory effects and potential mild blood-thinning properties, Epimedium may interact with phosphodiesterase type 5 (PDE5) inhibitors (e.g., sildenafil) and anticoagulant medications (blood thinners), potentially increasing their effects. Although data are limited, individuals on these medications should consult a healthcare provider before use. Epimedium is contraindicated in patients on blood thinners or those with hormone-sensitive conditions, given its potential, albeit unconfirmed, hormonal influences. Insufficient data exist regarding its safety during pregnancy and lactation, so its use is not recommended in these populations. Studies have primarily focused on adults with osteoporosis or erectile dysfunction; therefore, its safety in children or severely ill patients has not been established.

Dosage

The optimal dosage of Epimedium Leaf Extract varies depending on the specific condition and the standardization of the extract, particularly its icariin content. Clinical trials for osteoporosis have typically used extracts providing 60 to 200 mg of icariin per day. For general use, standardized extracts with quantified icariin content are preferred to ensure consistency and efficacy. While a maximum safe dose is not firmly established, traditional use and clinical trials suggest that doses up to 500 mg/day of total flavonoids are generally well tolerated. For the management of osteoporosis, daily dosing over several months is typical to observe benefits on bone metabolism. For erectile dysfunction, some studies have indicated that dosing approximately one hour before sexual activity may be effective. The absorption and bioavailability of icariin may be enhanced when taken with food or through specific formulations. No specific cofactors are identified as required for its efficacy.

FAQs

Is Epimedium effective for osteoporosis?

Yes, meta-analyses indicate that Epimedium total flavonoids can modestly improve bone mineral density and reduce markers of bone turnover in individuals with primary osteoporosis.

Can it improve erectile dysfunction?

Some randomized controlled trials suggest a benefit in improving erectile function scores, though often in formulations combined with other herbs. Single-ingredient efficacy requires further research.

Is Epimedium safe for long-term use?

Epimedium is generally considered safe at studied doses, with mild side effects. However, long-term safety data from extensive clinical trials are still limited.

When should Epimedium be taken?

For sexual function, it's often suggested to take it about one hour before activity. For bone health, consistent daily dosing over several months is typically recommended.

Does Epimedium interact with other medications?

Possible interactions exist with blood thinners and PDE5 inhibitors due to its vasodilatory and potential blood-thinning effects. Consult a healthcare provider if you are on these medications.

Research Sources

https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1505926/full – This systematic review and meta-analysis by Li et al. (2024) found that Epimedium total flavonoids significantly improved bone mineral density (BMD) and reduced bone turnover markers in patients with primary osteoporosis, demonstrating a good safety profile. The study synthesized data from multiple randomized controlled trials, highlighting the potential of Epimedium as an adjunctive therapy for osteoporosis.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9008843/ – Shi et al. (2022) conducted a systematic review and meta-analysis involving 438 patients across four RCTs, concluding that Epimedium decoction was superior to conventional therapy in reducing alkaline phosphatase, a bone turnover marker. While showing promise for bone health, the study noted limitations due to the variable quality and limited number of included RCTs.
https://www.publish.csiro.au/hc/pdf/HC24183 – This systematic review and meta-analysis by Lee & Barnes (2025) analyzed data from 1017 middle-aged and older adults. It indicated that Epimedium, particularly when combined with conventional therapy, improved BMD and showed modest improvements in erectile function scores in some trials. The review highlighted the confounding effects of multi-herb products and the need for more single-ingredient trials.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1415265/full – Cui et al. (2024) provided a narrative review with meta-analysis of preclinical and clinical data, demonstrating that Epimedium flavonoids inhibit inflammatory pathways (NF-κB/MAPK), reduce inflammatory cytokines, and contribute to improved bone metabolism. The review primarily focused on the mechanistic rationale, with most anti-inflammatory evidence derived from preclinical studies.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3551978/ – Shindel et al. (2010) conducted a review of preclinical and clinical studies on icariin, the active compound in Epimedium. The review concluded that icariin acts as a PDE5 inhibitor, which explains its ability to improve erectile function in animal models and small human trials. It emphasized the need for larger, well-designed randomized controlled trials to confirm these findings in humans.